Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trial.
Atwine D, Baudin E, Gelé T, Muyindike W, Mworozi K, Kyohairwe R, Kananura K, Orikiriza P, Nyehangane D, K T Nanjebe D, Furlan V, Verstuyft C, Barrail-Tran A, Taburet AM, Bonnet M; ANRS 12292 Rifavirenz study group.
Atwine D, et al. Among authors: taburet am.
J Antimicrob Chemother. 2020 May 1;75(5):1250-1258. doi: 10.1093/jac/dkz557.
J Antimicrob Chemother. 2020.
PMID: 31999314
Clinical Trial.